Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons

Neuroscience. 2001;104(3):901-12. doi: 10.1016/s0306-4522(01)00113-0.

Abstract

Alpha-synuclein accumulates in the brains of sporadic Parkinson's disease patients as a major component of Lewy bodies, and mutations in alpha-synuclein are associated with familial forms of Parkinson's disease. The pathogenic mechanisms that precede and promote the aggregation of alpha-synuclein into Lewy bodies in neurons remain to be determined. Here, we constructed a series of alpha-synuclein-enhanced green fluorescent protein (alpha-synucleinEGFP, SynEGFP) fusion proteins to address whether the Parkinson's disease-associated mutations alter the subcellular distribution of alpha-synuclein, and to use as a tool for experimental manipulations to induce aggregate formation. When transfected into mouse cultured primary neurons, the 49-kDa alpha-synucleinEGFP fusion proteins are partially truncated to a approximately 27-kDa form. This non-fluorescent carboxy-terminally modified fusion protein spontaneously forms inclusions in the neuronal cytoplasm. A marked increase in the accumulation of inclusions is detected following treatment with each of three proteasome inhibitors, n-acetyl-leu-leu-norleucinal, lactacystin and MG132. Interestingly, Ala30Pro alpha-synucleinEGFP does not form the cytoplasmic inclusions that are characteristic of wild-type and Ala53Thr alpha-synucleinEGFP, supporting the idea that the Ala30Pro alpha-synuclein protein conformation differs from wild-type alpha-synuclein. Similar inclusions are formed if alpha-synuclein carboxy-terminus is modified by the addition of a V5/6xHistidine epitope tag. By contrast, overexpression of unmodified alpha-synuclein does not lead to aggregate formation. Furthermore, synphilin-1, an alpha-synuclein interacting protein also found in Lewy bodies, colocalizes with the carboxy-terminally truncated alpha-synuclein fusion protein in discrete cytoplasmic inclusions.Our finding that manipulations of the carboxy-terminus of alpha-synuclein lead to inclusion formation may provide a model for studies of the pathogenic mechanisms of alpha-synuclein aggregation in Lewy bodies.

MeSH terms

  • Animals
  • Brain / metabolism
  • Brain / pathology
  • Brain / physiopathology
  • Carrier Proteins / metabolism
  • Cerebral Cortex / cytology
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Cryoprotective Agents / pharmacology
  • Cysteine Endopeptidases / metabolism
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dimethyl Sulfoxide / pharmacology
  • Fetus
  • Genes, Reporter / physiology
  • Green Fluorescent Proteins
  • Humans
  • Immunohistochemistry
  • Inclusion Bodies / metabolism*
  • Inclusion Bodies / pathology
  • Intracellular Signaling Peptides and Proteins
  • Leupeptins / pharmacology
  • Luminescent Proteins / genetics
  • Luminescent Proteins / metabolism*
  • Mice
  • Multienzyme Complexes / antagonists & inhibitors*
  • Multienzyme Complexes / metabolism
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Neurons / metabolism*
  • Neurons / pathology
  • Parkinson Disease / genetics
  • Parkinson Disease / metabolism*
  • Parkinson Disease / physiopathology
  • Proteasome Endopeptidase Complex
  • Protein Structure, Tertiary / drug effects
  • Protein Structure, Tertiary / physiology
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism*
  • Synucleins
  • Tumor Cells, Cultured / cytology
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism
  • alpha-Synuclein

Substances

  • Carrier Proteins
  • Cryoprotective Agents
  • Cysteine Proteinase Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • Leupeptins
  • Luminescent Proteins
  • Multienzyme Complexes
  • Nerve Tissue Proteins
  • Recombinant Fusion Proteins
  • SNCA protein, human
  • SNCAIP protein, human
  • Snca protein, mouse
  • Sncaip protein, mouse
  • Synucleins
  • alpha-Synuclein
  • acetylleucyl-leucyl-norleucinal
  • Green Fluorescent Proteins
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • Dimethyl Sulfoxide